Drugs / FMT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02530385 | Jun 2016 → Jun 2018 | obesity disorder | Massachusetts General Hospital | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02530385 ↗ |
| Route | Oral | “We investigated the safety of weekly oral fecal microbiota transplantation (FMT) capsules from healthy lean donors” PMID 32150549 ↗ Mar 2020 |